Branding Clinical Research Dermatology 
Pharmaceutical Technology
FEBRUARY 24, 2023
Douglas provides products in various therapeutic areas which include psoriasis, eczema, dermatitis, chicken pox, constipation, laxative, neonatal, hormone regulation, dermatology, cardiovascular and measles, among others. Douglas collaborates with scientific researchers and external medical experts to advance clinical research.
Pharmaceutical Technology
FEBRUARY 24, 2023
Douglas provides products in various therapeutic areas which include psoriasis, eczema, dermatitis, chicken pox, constipation, laxative, neonatal, hormone regulation, dermatology, cardiovascular and measles, among others. Douglas collaborates with scientific researchers and external medical experts to advance clinical research.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Olympian Clinical Research
FEBRUARY 13, 2024
At Academic Alliance in Dermatology, we understand the importance of using products that not only care for your skin on the surface but also work effectively at a cellular level. This is where medical-grade skincare like SkinCeuticals, ZO, Colorescience, Obagi, SkinMedica and Alastin distinctly outshine drugstore brands.
Olympian Clinical Research
MAY 7, 2024
A common question we hear at Academic Alliance in Dermatology is: “How long do fillers last?” Popular Brands and Their Benefits Each brand offers products designed for specific needs: Juvéderm ® : Known for its smooth texture, Juvéderm works well for adding cheek volume, smoothing lines, and enhancing lips.
The Pharma Data
DECEMBER 17, 2020
Martin Carter Professor in Clinical Investigation and Head of the Laboratory of Investigative Dermatology at The Rockefeller University and Weinblatt is the co-director of Clinical Rheumatology at the Brigham and Women’s Hospital.
Pharmaceutical Technology
JANUARY 25, 2023
Supply chains and the clinical researchers relying on them received another shock following Russia’s invasion of Ukraine on 24 th February 2022. A GlobalData survey found that researchers judged decentralised trials to be almost twice as suitable in therapies for metabolic disorders and dermatology compared with immunology.
Pharmaceutical Technology
JANUARY 25, 2023
Supply chains and the clinical researchers relying on them received another shock following Russia’s invasion of Ukraine on 24 th February 2022. A GlobalData survey found that researchers judged decentralised trials to be almost twice as suitable in therapies for metabolic disorders and dermatology compared with immunology.
Expert insights. Personalized for you.
100 
Let's personalize your content